发明名称 |
VEGF ANTAGONIST FORMULATIONS |
摘要 |
Formulations of a vascular endothelial growth factor (VEGF)-specific fusion protein antagonist are provided including a pre-lyophilized formulation, a reconstituted lyophilized formulation, and a stable liquid formulation. Preferably, the fusion protein has the sequence of SEQ ID NO:4. |
申请公布号 |
EP1861116(A2) |
申请公布日期 |
2007.12.05 |
申请号 |
EP20060748594 |
申请日期 |
2006.03.22 |
申请人 |
REGENERON PHARMACEUTICALS, INC. |
发明人 |
DIX, DANIEL;FRYE, KELLY;KAUTZ, SUSAN |
分类号 |
A61K38/17;A61K47/00 |
主分类号 |
A61K38/17 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|